SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 73 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 7.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $341,250 | -70.7% | 50,000 | -52.2% | 0.00% | -76.9% |
Q3 2020 | $1,165,000 | +824.6% | 104,524 | +99.1% | 0.01% | +1200.0% |
Q4 2018 | $126,000 | -20.8% | 52,506 | +45.4% | 0.00% | 0.0% |
Q3 2018 | $159,000 | +123.9% | 36,100 | +161.6% | 0.00% | – |
Q1 2018 | $71,000 | – | 13,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paloma Partners Management Co | 3,775,000 | $1,359,000 | 0.05% |
Oaktree Fund Advisors, LLC | 66,000 | $23,760 | 0.02% |
GoalVest Advisory LLC | 32,915 | $11,849 | 0.01% |
Houlihan Financial Resource Group, Ltd. | 30,000 | $11 | 0.01% |
Granite Bay Wealth Management, LLC | 22,520 | $8 | 0.01% |
S&T BANK/PA | 38,853 | $14 | 0.00% |
Lattice Capital Management, LLC | 51,800 | $18,648 | 0.00% |
Modus Advisors, LLC | 19,706 | $7,094 | 0.00% |
Crescent Grove Advisors, LLC | 60,000 | $21,600 | 0.00% |
SlateStone Wealth, LLC | 21,433 | $8 | 0.00% |